This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arnett-Mansfield, R. L. Articles by Clarke, C. L. Search for Related Content PubMed PubMed Citation Articles by Arnett-Mansfield, R. L. Articles by Clarke, C. L.

Subnuclear Distribution of Progesterone Receptors A and B in Normal and Malignant Endometrium

Westmead Institute for Cancer Research (R.L.A.-M., A.deF., P.A.M., C.L.C.), University of Sydney at the Westmead Millennium Institute; and Department of Gynaecological Oncology (A.deF.), Westmead Hospital, Westmead, New South Wales 2145, Australia

Address all correspondence and requests for reprints to: Rebecca Arnett-Mansfield, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales 2145, Australia. E-mail: rebecca_arnett{at}wmi.usyd.edu.au or christine_clarke{at}wmi.usyd.edu.au.

The nuclear progesterone receptor (PR), which is expressed as two proteins with different functions (PRA and PRB), is expressed in the normal endometrium and endometrial cancer. Our previous work has shown that there is a disruption to the relative PR isoform expression in progression to malignancy in endometrial cancer in which expression of a single isoform is common. A consistent feature in these studies was discrete punctate distribution of PRA and PRB in the nuclei of endometrial cancer cells. In this study PRA and PRB distribution within the nucleus was examined in vivo in the normal endometrium during the menstrual cycle, and in endometrial cancer, by dual immunofluorescence and confocal microscopy using cohorts in which PRA and PRB expression levels have previously been characterized. In the normal endometrium, PR was distributed evenly within the nucleus and also localized in discrete subnuclear foci. In the proliferative phase, even PR distribution was predominant and both PR isoforms were colocated and distributed evenly. In the secretory phase, there was a marked increase in the proportion of nuclei containing PR distributed into discrete foci, and PRB was the predominant isoform in nuclear foci. There was an inverse relationship between even and focal PR distribution in the menstrual cycle, suggesting that hormonal fluctuations were involved in movement of PR into focal nuclear locations. In endometrial cancers colocalization of PRA and PRB was infrequent, and there was no relationship between even and focal PR isoform distribution, unlike the normal endometrium. PRA was predominantly evenly distributed in endometrial cancers, whereas PRB was focal. Even PRB distribution in endometrial cancer was not often noted. Multivariate analysis showed that PRA expression was highly predictive of even nuclear distribution in endometrial cancers and PRB expression of distribution into foci, and these associations were independent of total PRA and PRB levels. Nuclear distribution of PR isoforms was associated with clinical grade, where tumors of high grade had significantly fewer nuclei containing even PRA distribution and focal PRB distribution, compared with tumors of low grade. In the normal endometrium, localization of PR into nuclear foci coincides with high progesterone levels, suggesting that altered intranuclear PR distribution is hormonally regulated. Nuclear distribution may be an important component of gene regulation in target tissues, and disruptions in PR distribution in endometrial cancer could affect the function of PR and contribute to aberrant hormonal responses.

This work was supported by the National Health and Medical Research Council of Australia, the Leo and Jenny Leukemia and Cancer Foundation, and the Westmead Millennium Foundation.

Abbreviations: AR, Androgen receptor; CI, confidence interval; ER, estrogen receptor; FIGO, Fédération Internationale de Gynécologie et d’Obstétrique; FITC, fluorescein isothiocyanate; GFP, green fluorescent protein; GR, glucocorticoid receptor; HRT, hormone replacement therapy; MR, mineralocorticoid receptor; OR, odds ratio; PR, progesterone receptor; RNA pol II, RNA polymerase II; SRC, steroid receptor coactivator; TXR, Texas red.

This article has been cited by other articles:

				M. M White, I. Sheffer, J. Teeter, and E. M. Apostolakis Hypothalamic progesterone receptor-A mediates gonadotropin surges, self priming and receptivity in estrogen-primed female mice J. Mol. Endocrinol., January 1, 2007; 38(1): 35 - 50. [Abstract] [Full Text] [PDF]

				R. L. Arnett-Mansfield, J. D. Graham, A. R. Hanson, P. A. Mote, A. Gompel, L. L. Scurr, N. Gava, A. de Fazio, and C. L. Clarke Focal Subnuclear Distribution of Progesterone Receptor Is Ligand Dependent and Associated with Transcriptional Activity Mol. Endocrinol., January 1, 2007; 21(1): 14 - 29. [Abstract] [Full Text] [PDF]

				S. C. Hewitt The Five W's of Progesterone Receptors A and B: Now We Know Where and When. Endocrinology, December 1, 2006; 147(12): 5501 - 5502. [Full Text] [PDF]

				P. A. Mote, R. L. Arnett-Mansfield, N. Gava, A. deFazio, B. Mulac-Jericevic, O. M. Conneely, and C. L. Clarke Overlapping and Distinct Expression of Progesterone Receptors A and B in Mouse Uterus and Mammary Gland during the Estrous Cycle Endocrinology, December 1, 2006; 147(12): 5503 - 5512. [Abstract] [Full Text] [PDF]

				R. Pilka, I. Oborna, V. Lichnovsky, P. Havelka, H. Fingerova, P. Eriksson, S. Hansson, and B. Casslen Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients Hum. Reprod., December 1, 2006; 21(12): 3146 - 3156. [Abstract] [Full Text] [PDF]

				L. Albitar, L. L. Laidler, R. Abdallah, and K. K. Leslie Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type I and II tumors Mol. Cancer Ther., December 1, 2005; 4(12): 1891 - 1899. [Abstract] [Full Text] [PDF]

				P.B. Marshburn, J. Zhang, Z.B. Mostafavi, M.L. Matthews, J. White, and B.S. Hurst Variant progesterone receptor mRNAs are co-expressed with the wild-type progesterone receptor mRNA in human endometrium during all phases of the menstrual cycle Mol. Hum. Reprod., November 1, 2005; 11(11): 809 - 815. [Abstract] [Full Text] [PDF]

				N. Chabbert-Buffet, G. Meduri, P. Bouchard, and I. M. Spitz Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications Hum. Reprod. Update, May 1, 2005; 11(3): 293 - 307. [Abstract] [Full Text] [PDF]